CytoSorbents shareholders elect directors, approve executive compensation and auditor at 2025 annual meeting

Cytosorbents Corp

All five director nominees (Phillip P. Chan, Edward R. Jones, Michael Bator, Alan D. Sobel, Jiny Kim) were elected with strong support.
Non-binding advisory vote on named executive officer compensation passed with 18,189,951 for, 1,720,512 against, and 2,741,091 abstain.
Ratification of WithumSmith+Brown, PC as independent auditor for fiscal year 2025 approved with 39,485,868 for and 553,680 against.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.